凯赛生物: 2025年第二次临时股东大会决议公告

Meeting Overview - The shareholders' meeting of Shanghai Kaisa Biotechnology Co., Ltd. was held on August 18, 2025, in Shanghai [1] - A total of 171 ordinary shareholders attended the meeting, holding 517,786,578 voting rights, which represents 72.02% of the company's total voting rights [1] Voting Results - All non-cumulative voting proposals were approved with significant support, including: - 99.5553% of ordinary shareholders voted in favor of the first proposal, with 2,255,339 votes against and 47,043 abstentions [1] - The second proposal received 99.5533% approval, with 2,265,639 votes against and 47,043 abstentions [1] - The third proposal had 99.5576% approval, with 2,243,639 votes against and 47,043 abstentions [1] Election of Directors - The meeting included the election of several directors, all of which were approved: - XIUCAI LIU was elected as a non-independent director [2] - DENG WEIDONG, LU YIYANG, ZANG HUIQING, and YANG CHEN were also elected as non-independent directors [3] - WU XIANGYANG, SHANG JIANGANG, and LIAN LISHUAI were elected as independent directors [3] Legal Compliance - The meeting was conducted in accordance with relevant laws, regulations, and the company's articles of association, ensuring the legality and validity of the proceedings and voting results [3]